Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 73

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 73
---
 directors’ assessment, in the case of our chief executive officer) of the NEO’s individual performance and our overall company performance, in each case without reference to any specific metric.

|                            |     | 2024 Annual Stock 
 Option Awards (1) |         |     | 2024 Annual RSU 
 Awards (2)      |        |     | 2024 Annual PSU 
 Awards (3)      |        |
| Brian Goff                 |     |                   | 195,500 |     |                 | 54,000 |     |                 | 54,000 |
| Cecilia Jones              |     |                   |  60,000 |     |                 | 17,000 |     |                 | 17,000 |
| James Burns                |     |                   |  60,000 |     |                 | 17,000 |     |                 | 17,000 |
| Sarah Gheuens, M.D., Ph.D. |     |                   |  60,000 |     |                 | 17,000 |     |                 | 17,000 |
| Tsveta Milanova            |     |                   |  60,000 |     |                 | 17,000 |     |                 | 17,000 |

| (1) | The options have an exercise price of $32.27 per share, the closing price on the date of grant. The options are subject to time-based vesting, with 25% of the shares underlying the award vesting on the first anniversary of the grant date and the remaining shares vesting monthly thereafter in equal increments over 36 months, subject to continued service. |

| (2) | The RSUs are subject to time-based vesting, with one-third of the shares of common stock underlying the RSUs vesting on the first, second and third anniversaries of the grant date, subject to continued service. |

| (3) | The PSUs vest as to (i) with respect to Mr. Goff, one-fourth of the underlying shares of common stock upon the achievement of a specified regulatory milestone and three-fourths of the underlying shares of common stock upon the achievement of a specified commercial milestone; and (ii) with respect to our other NEOs, one-half of the underlying shares of common stock upon the achievement of each of one specified regulatory and one specified commercial milestone, in each case subject to continued service. |

Performance Share Units (PSUs) In addition to